Smooth muscle K Ca 3.1 limits plaque progression and alters plaque composition in mice
Increased expression of KCa3.1 has been found in vascular smooth muscle cells (SMC), macrophages, and T cells in atherosclerotic lesions from humans and mice. While the efficacy of pharmacological inhibition and global silencing of KCa3.1 in limiting atherosclerosis has been demonstrated, the relative cell-specific contributions of KCa3.1 have not been determined. Therefore, we generated a smooth muscle (SMC) specific inducible KCa3.1-/- mouse with global Apoe-/- knockout (iSMKO) and assessed lesion development in the brachiocephalic artery (BCA) of tamoxifen vs. vehicle injected iSMKO mice on a Western diet (WD) for 15 or 40 weeks. In BCAs of iSMKO mice, lesion size and relative stenosis were increased and lumenal area decreased compared to vehicle injected mice. Additionally, iSMKO mice exhibited a significant reduction in SMC and collagen content at 15 weeks and 40 weeks, while macrophage content increased at 40 weeks. RNAseq analysis of BCA samples from tamoxifen and vehicle injected iSMKO mice prior to WD feeding (baseline) indicated increased mitochondrial function and PPAR-dependent signaling, similar to that found in prior studies of global KCa3.1 silencing. However, following 15 weeks of WD and induction of disease, these differences were no longer observed. Overall, this study provides the first cell-specific silencing of KCa3.1 to elucidate the contribution of KCa3.1 in smooth muscle to prior observations of KCa3.1 silencing. Our findings reveal both a beneficial role of SMC KCa3.1 in limiting plaque size and macrophage infiltration, and a potentially detrimental effect of reducing plaque SMC and collagen content. Combined with previous studies, this raises caution in the use of pharmacological KCa3.1 inhibitors in atherosclerosis and highlights the need for cell-specific targeting of KCa3.1 in optimizing potential therapies.
Authors
- Perwez Alam (ORCID: https://orcid.org/0000-0002-7229-8008)
- Douglas K. Bowles (ORCID: https://orcid.org/0000-0003-2043-7368)
- Shawn B. Bender (ORCID: https://orcid.org/0000-0003-4709-1387)
- Darla L. Tharp (ORCID: https://orcid.org/0009-0002-2543-2961)
- Hunter J Bowles
- Hieu Bui
Institutions
- University of Missouri (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-16
- DOI
- https://doi.org/10.64898/2026.11.12.766210
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- preprint
Funders
- American Heart Association
- National Institutes of Health